Karyopharm Therapeutics (KPTI) Accumulated Expenses (2012 - 2026)
Karyopharm Therapeutics (KPTI) reported Accumulated Expenses of $78.8 million for Q2 2026, up 25.2% from $62.93 million a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Accumulated Expenses (2012 - 2026) Analysis & Trends
At the end of FY2025, Karyopharm Therapeutics posted Accumulated Expenses of $64.5 million, up 6.3% from FY2024.
- Accumulated Expenses has a five-year compound annual growth rate of 4.0% (FY2020 to FY2025).
- By year, Accumulated Expenses came in at $60.65 million in FY2024 (-1.2%), $61.39 million in FY2023 (+5.1%), $58.42 million in FY2022 (-15.5%) and $69.12 million in FY2021 (+30.6%).
- The Q2 2026 figure ranks as the highest quarterly Accumulated Expenses in data going back to Q4 2012.
- Year over year, Accumulated Expenses gained in five of the last seven quarters, with growth averaging 11.9%.
- The high point for year-over-year Accumulated Expenses in five years was Q3 2021 (growth of 38.9%); the low point was Q1 2023 (a decline of 19.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Karyopharm Therapeutics | 15.92 Mn | -210.51 Mn | 32.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 78.80 Mn |
| Dec 31, 2025 | 64.50 Mn |
| Sep 30, 2025 | 66.33 Mn |
| Jun 30, 2025 | 62.93 Mn |
| Mar 31, 2025 | 57.17 Mn |
| Dec 31, 2024 | 60.65 Mn |
| Sep 30, 2024 | 50.11 Mn |
| Jun 30, 2024 | 49.81 Mn |
| Mar 31, 2024 | 54.85 Mn |
| Dec 31, 2023 | 61.39 Mn |
| Sep 30, 2023 | 55.71 Mn |
| Jun 30, 2023 | 51.81 Mn |
| Mar 31, 2023 | 47.03 Mn |
| Dec 31, 2022 | 58.42 Mn |
| Sep 30, 2022 | 55.72 Mn |
| Jun 30, 2022 | 56.37 Mn |
| Mar 31, 2022 | 58.37 Mn |
| Dec 31, 2021 | 69.12 Mn |
| Sep 30, 2021 | 64.70 Mn |
| Jun 30, 2021 | 53.21 Mn |
API Access
Karyopharm Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();